Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 374
1 302 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$212.83 |
+1.6%
|
$376.4B |
|
|
|
Amgen Inc
AMGN
|
$331.97 |
+2.3%
|
$179.2B |
|
|
|
Gilead Sciences Inc
GILD
|
$130.62 |
+0.7%
|
$162.1B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$428.96 |
-1.7%
|
$109.1B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$645.59 |
+2.5%
|
$68.3B |
|
|
|
argenx SE
ARGX
|
€690.4 |
+2.2%
|
$49.6B |
|
|
|
Alnylam Pharmaceuticals Inc
ALNY
|
$294.62 |
+2.9%
|
$39.3B |
|
|
|
CSL Ltd
CSL
|
AU$98.285 |
+2.1%
|
$34.2B |
|
|
|
Beigene Ltd
688235
|
¥239.97 |
-4.8%
|
$31.5B |
1 297 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
